Earnings Mentions for Johnson & Johnson

Historical counts of specific terms mentioned on earnings calls. See earnings mentions demo here.

Transcripts Shown
Transcript Type
Overall Yes Rate55%
Next Earnings
Jul 15, 2026
Latest Transcript
Apr 14, 2026
China
Yes
90¢
No
19¢
25/25(100%)
Quarters w/ Yes
154Total Mentions
2026 Q1Last Mentioned
Europe
Yes
90¢
No
21¢
24/25(96%)
Quarters w/ Yes
96Total Mentions
2026 Q1Last Mentioned
Administration
Yes
62¢
No
40¢
9/25(36%)
Quarters w/ Yes
20Total Mentions
2025 Q4Last Mentioned
Darzalex Faspro
Yes
72¢
No
35¢
8/25(32%)
Quarters w/ Yes
12Total Mentions
2026 Q1Last Mentioned
AI / Artificial Intelligence
Yes
26¢
No
75¢
3/25(12%)
Quarters w/ Yes
3Total Mentions
2023 Q4Last Mentioned
You're only seeing data for 5 of 15 words. To see data for the words below, try Prediction Markets Pro free for 7 days.
Gene Therapy
Yes
26¢
No
84¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Halda Therapeutics
Yes
51¢
No
63¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Litigation
Yes
83¢
No
70¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Nipocalimab / Lupus
Yes
70¢
No
34¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Ottava
Yes
90¢
No
13¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Procedure
Yes
89¢
No
70¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Rybrevant
Yes
90¢
No
15¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Tariff
Yes
84¢
No
47¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Trufill
Yes
25¢
No
90¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Vaccine
Yes
11¢
No
90¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned